Creative Edge Nutrition, Inc. Letter to Shareholders - Seite 2

An example of such untruths is the rumor that CEN Biotech failed to satisfy the zoning requirements of the Town of Lakeshore, where the initial facility is located. However, contrary to this misrepresentation, the town council of Lakeshore specifically determined that CEN Biotech's facility was properly zoned as agricultural as well as indicating that CEN Biotech had requested to grow 600,000 kg of dried marijuana. Documentation of these facts is contained on pages 31-32 of the official Minutes of the Lakeshore November 12, 2013 Town Council meeting, which may be found in the link below.

http://weblink8.lakeshore.ca/WebLink8/DocView.aspx?id=9666&dbid=1

The Company has the highest confidence in the federal court to finally have an unbiased and scrupulous review of the true facts involved with its application, which facts the Company believes will prove to the Court that CEN Biotech has in fact complied with all requirements under the MMPR for issuance of a license to grow. 

CEN Biotech remains committed to protecting its loyal shareholders' equity investments, (as has been the case since Health Canada issued the Company a "Ready to build" letter) by exhausting all legal avenues available for procurement of a license to grow. We ask that you trust in our quest for transparency, which has been our goal since the inception of the Company. Because of your support, and the respect in our vision, we are here today and that is the sole reason we will be here tomorrow.

Hopefully, as we believe, the Company will be successful in the mandamus suit presently pending in federal court, and we can move forward toward providing those patients in need (most notably the children who depend on such medicine to curb epileptic and other seizures) with quality medicinal marijuana.

About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC PINK: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada. http://www.cenbiotechinc.com [e-mail]